LakeShore Biopharma Co., Ltd (LSBCF) — Cash Flow Quality Index
Latest as of June 2022:
-0.06x
LakeShore Biopharma Co., Ltd (LSBCF) has a Cash Flow Quality Index of -0.06x as of June 2022. Operating cash flow of $-693.96K is below net income of $11.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore LakeShore Biopharma Co., Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.06x
Operating CF / Net Income
Operating Cash Flow
$-693.96K
USD
Net Income
$11.52 Million
USD
Data as of
Jun 2022
Most recent filing
Annual Cash Flow Quality Index for LakeShore Biopharma Co., Ltd (None–None)
Year-by-year earnings quality comparison for LakeShore Biopharma Co., Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.